GENE ONLINE|News &
Opinion
Blog

Immunotherapy
Trials & Approvals Immunotherapy
FDA Fast Tracks Celgene Spinoff’s NK Cell Therapy for Treating Aggressive Brain Tumor
2021-03-21
Funding oNK Cell Therapy
Acepodia Raises $47 Million Funding to Nurture its Next-Gen, oNK Cell Therapy Assets
2021-03-17
R&D Lung Cancer
After Cardiovascular Disease, Novartis’ Rare Disease Drug Flops in Late-Stage Lung Cancer Study
2021-03-09
R&D Immunotherapy
Researchers Design Novel Bispecific Antibodies to Nab “Hard-to-Target” Cancer Drivers
2021-03-09
R&D CAR-T Technology
Interferon-γ Pathway Helps Cancer Cells Evade Immune Therapy
2021-02-28
Trials & Approvals PD-1 Inhibitor
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Trials & Approvals PD-1 Inhibitor
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
China’s Adagene Gears Up for IPO, Seeking 125 Million for Cancer Therapy Development
2021-01-24
Cancer
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
China’s Gracell Biotechnologies, a CAR-T Therapy Company, Targets 150 Million for IPO
2021-01-13
Trials & Approvals
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
phar-east 2020
Over 1000 Pharma & Biotech players across Asia and beyond to gather virtually in December!
2020-11-27
R&D Immunotherapy
Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy
2020-11-22
Trials & Approvals CAR-T Cell
Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange
2020-11-04
R&D PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
1 2 3 4 5 6 7
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top